450 related articles for article (PubMed ID: 29321332)
1. ERK Is a Critical Regulator of JC Polyomavirus Infection.
DuShane JK; Wilczek MP; Mayberry CL; Maginnis MS
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321332
[TBL] [Abstract][Full Text] [Related]
2. JC Polyomavirus Entry by Clathrin-Mediated Endocytosis Is Driven by β-Arrestin.
Mayberry CL; Soucy AN; Lajoie CR; DuShane JK; Maginnis MS
J Virol; 2019 Apr; 93(8):. PubMed ID: 30700597
[TBL] [Abstract][Full Text] [Related]
3. The Greater Affinity of JC Polyomavirus Capsid for α2,6-Linked Lactoseries Tetrasaccharide c than for Other Sialylated Glycans Is a Major Determinant of Infectivity.
Ströh LJ; Maginnis MS; Blaum BS; Nelson CD; Neu U; Gee GV; O'Hara BA; Motamedi N; DiMaio D; Atwood WJ; Stehle T
J Virol; 2015 Jun; 89(12):6364-75. PubMed ID: 25855729
[TBL] [Abstract][Full Text] [Related]
4. Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.
Maginnis MS; Ströh LJ; Gee GV; O'Hara BA; Derdowski A; Stehle T; Atwood WJ
mBio; 2013 Jun; 4(3):e00247-13. PubMed ID: 23760462
[TBL] [Abstract][Full Text] [Related]
5. JCPyV-Induced MAPK Signaling Activates Transcription Factors during Infection.
DuShane JK; Mayberry CL; Wilczek MP; Nichols SL; Maginnis MS
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561471
[TBL] [Abstract][Full Text] [Related]
6. JC polyomavirus attachment, entry, and trafficking: unlocking the keys to a fatal infection.
Maginnis MS; Nelson CD; Atwood WJ
J Neurovirol; 2015 Dec; 21(6):601-13. PubMed ID: 25078361
[TBL] [Abstract][Full Text] [Related]
7. JC Polyomavirus Infection Reveals Delayed Progression of the Infectious Cycle in Normal Human Astrocytes.
Wilczek MP; DuShane JK; Armstrong FJ; Maginnis MS
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826993
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of Primary Human Choroid Plexus Epithelial Cells and Meningeal Cells to Infection by JC Virus.
O'Hara BA; Gee GV; Atwood WJ; Haley SA
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437972
[TBL] [Abstract][Full Text] [Related]
9. JC Polyomavirus Attachment and Entry: Potential Sites for PML Therapeutics.
Mayberry CL; Nelson CDS; Maginnis MS
Curr Clin Microbiol Rep; 2017 Sep; 4(3):132-141. PubMed ID: 28989857
[TBL] [Abstract][Full Text] [Related]
10. 5-HT2 receptors facilitate JC polyomavirus entry.
Assetta B; Maginnis MS; Gracia Ahufinger I; Haley SA; Gee GV; Nelson CD; O'Hara BA; Allen Ramdial SA; Atwood WJ
J Virol; 2013 Dec; 87(24):13490-8. PubMed ID: 24089568
[TBL] [Abstract][Full Text] [Related]
11. GRK2 mediates β-arrestin interactions with 5-HT
Mayberry CL; Wilczek MP; Fong TM; Nichols SL; Maginnis MS
J Virol; 2021 Mar; 95(7):. PubMed ID: 33441347
[TBL] [Abstract][Full Text] [Related]
12. The Oxindole GW-5074 Inhibits JC Polyomavirus Infection and Spread by Antagonizing the MAPK-ERK Signaling Pathway.
Kaiserman J; O'Hara BA; Garabian K; Lukacher A; Haley SA; Atwood WJ
mBio; 2023 Apr; 14(2):e0358322. PubMed ID: 36786589
[TBL] [Abstract][Full Text] [Related]
13. High-throughput drug screen identifies calcium and calmodulin inhibitors that reduce JCPyV infection.
Bond ACS; Crocker MA; Wilczek MP; DuShane JK; Sandberg AL; Bennett LJ; Leclerc NR; Maginnis MS
Antiviral Res; 2024 Feb; 222():105817. PubMed ID: 38246207
[TBL] [Abstract][Full Text] [Related]
14. The MAPK/ERK Pathway and the Role of DUSP1 in JCPyV Infection of Primary Astrocytes.
Wilczek MP; Armstrong FJ; Geohegan RP; Mayberry CL; DuShane JK; King BL; Maginnis MS
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578413
[TBL] [Abstract][Full Text] [Related]
15. High expression of JC polyomavirus-encoded microRNAs in progressive multifocal leukoencephalopathy tissues and its repressive role in virus replication.
Takahashi K; Sato Y; Sekizuka T; Kuroda M; Suzuki T; Hasegawa H; Katano H
PLoS Pathog; 2020 Apr; 16(4):e1008523. PubMed ID: 32324824
[TBL] [Abstract][Full Text] [Related]
16. Human iPS cell-derived astrocytes support efficient replication of progressive multifocal leukoencephalopathy-type JC polyomavirus.
Shimbo E; Nukuzuma S; Tagawa YI
Biochem Biophys Res Commun; 2020 Dec; 533(4):983-987. PubMed ID: 33008586
[TBL] [Abstract][Full Text] [Related]
17. Modulation of a pore in the capsid of JC polyomavirus reduces infectivity and prevents exposure of the minor capsid proteins.
Nelson CD; Ströh LJ; Gee GV; O'Hara BA; Stehle T; Atwood WJ
J Virol; 2015 Apr; 89(7):3910-21. PubMed ID: 25609820
[TBL] [Abstract][Full Text] [Related]
18. Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
Jelcic I; Combaluzier B; Jelcic I; Faigle W; Senn L; Reinhart BJ; Ströh L; Nitsch RM; Stehle T; Sospedra M; Grimm J; Martin R
Sci Transl Med; 2015 Sep; 7(306):306ra150. PubMed ID: 26400911
[TBL] [Abstract][Full Text] [Related]
19. Dynamics and Patterning of 5-Hydroxytryptamine 2 Subtype Receptors in JC Polyomavirus Entry.
Mehmood K; Wilczek MP; DuShane JK; Parent MT; Mayberry CL; Wallace JN; Levasseur FL; Fong TM; Hess ST; Maginnis MS
Viruses; 2022 Nov; 14(12):. PubMed ID: 36560603
[TBL] [Abstract][Full Text] [Related]
20. Establishment of COS-JC cells persistently producing archetype JC polyomavirus.
Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Hidaka K; Takegami T
Microbiol Immunol; 2018 Aug; 62(8):524-530. PubMed ID: 29932215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
